FDA Investigator Celeta S Coves

Celeta S Coves has inspections in 1 countries as of 06 Nov 2023. Celeta S Coves has collaborated with a combinined 1503 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
60
Last Inspection Date:
06 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aleta T Flores, Alexander M Kay, Ana Djurdjevic, Anthony E Keller, RPh, Anthony N Onianwa, Arsen Karapetyan, Bryan A Galvez, Bryce A May, Cara M Minelli, Carol F Robinson, Catherine J Laufmann, Charles L Larson, Comyar Shoghi, Courtney N Long, Creighton T Tuzon, Deborah A Greco, Decarlos A Gomez, Dennis G Kawabata, Diana M Rand, Doretha M Tonkins, Doretha M Wilson, Dylan R Jock, Edward D Harris, Emily B Camire, Eric W Anderson, Eric Zhu, Erma Zaimova, Gabriel M Guevarra, Gene D Arcy, Gina C Collins, Gloria J Baca, MS, Graham N Giesen, James D Hildreth, Janet Pulver, Jocelyn E Massey, Ka L Wong, Karen J Bak, Kathleen B Swat, Kathryn A Krentz, Kelvin Cheung, Kenneth S Boehnen, Kimberly A Dux, Kirtida Patel, Laura E Garcia, Lauren E Swantko, Laurissa S Flowers, Leonard H Lavi, Lori J Silverstein, Mark W Babbitt, Mary Ewilkerson Brinsko, Maxyne T Lam, Michael A Blaine, Mpris Inspector, Naveen B Walker, Nikisha M Bolden, Peter Kessler, PhD, Phillip M Pontikos, Raymond W Brullo, Rebecca T Davis, Richard J Bashay, Robert B Shibuya, MD, Robert D Tollefsen, Robert S Sweeton, Sarah Forney, Scott K Zika, Seema S Singh, Selene T Torres, Shaquenta Y Perkins, Shelley H Beausoleil, Sonya L Karsik, Stephen R Souza, Steven E Porter, Jr, Tania Y Hall, Tawny L Colling, Terrance L Thomas, Thea C Grome, Timothy P Lafave, Tonia L Sawyer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vickie L Anderson, Vien Q Le, Virgilio F Pacio, CSO, William J Foust, Yvette Mlacour Davis, Yvonne C Wilkes, Yvonne T Lacour

Celeta S Coves's Documents

Publish Date Document Type Title
January, 2023 FDA 483 Response Regents of the University of California on behalf of UCLA Fertility and Reproductive Health Center - Form 483R, 2023-01-11
July, 2023 FDA 483 MD Tox Laboratory - Form 483, 2023-07-20
June, 2023 FDA 483 Blood Bank Computer Systems, Inc. - Form 483, 2023-06-30
March, 2023 FDA 483 Antibodies Inc - Form 483, 2023-03-10
May, 2022 FDA 483 BioLife Plasma Services L P - Form 483, 2022-05-27
May, 2023 FDA 483 Jeffrey M. Steinberg MD, Inc., a Professional Medical Corporation dba The Fertility Institutes - Form 483, 2023-05-16
February, 2023 FDA 483 Origin Biologics LLC - Form 483, 2023-02-10
March, 2023 FDA 483 The Center for Fertility & Gynecology - Form 483, 2023-03-20
January, 2023 FDA 483 Regents of the University of California on behalf of UCLA Fertility and Reproductive Health Center - Form 483, 2023-01-11
June, 2022 FDA 483 Meta Dental - Form 483, 2022-06-30
July, 2022 FDA 483 Newton Implant Systems, Inc. - Form 483, 2022-07-19
January, 2023 FDA 483 Southern California Center for Reproductive Medicine - Form 483, 2023-01-20
March, 2023 FDA 483 Loma Linda University Center for Fertility and IVF - Form 483, 2023-03-02
December, 2022 FDA 483 Lawrence Werlin MD, Inc. dba Coastal Fertility Medical Center - Form 483, 2022-12-22
April, 2023 FDA 483 University Fertility Laboratory, Inc. - Form 483, 2023-04-03
May, 2023 FDA 483 Incinta Fertility Center, LLC - Form 483, 2023-05-02
October, 2023 FDA 483 C.A.R.E. Fertility - Form 483, 2023-10-26
November, 2023 FDA 483 Huntington Reproductive Center Medical Group - Form 483, 2023-11-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more